Search Results 351-360 of 24244 for In situ
Previous or concurrent cancer that is distinct in primary site or histology from the cancer being evaluated in this study except: cervical carcinoma in situ ...
... in situ cervical cancer, or other cancer from which the subject has been disease free for ≥ 2 years or which will not limit survival to < 2 years; Known ...
in situ. 10. Disease modifying treatment prior to study enrollment, including but not limited to use of androgens, eltrombopag, romiplostim, or immune ...
... in situ (e.g., breast carcinoma, cervical cancer in situ) that have undergone potentially curative therapy are not excluded. Has known active CNS metastases ...
Acetylsalicylic Acid in Preventing Disease Recurrence in Patients With Barrett's Esophagus After Successful Elimination by Radiofrequency Ablation ... in-situ of ...
In situ cervical carcinoma; Adequately treated, papillary, non-invasive bladder cancer; Asymptomatic prostate cancer without known metastatic disease and with ...
EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix: NOTE: If there is a history of prior malignancy, they must not be receiving other ...
... in situ hybridization (FISH) assay and defined by an increase in the distance between 5' and 3' ALK probes or the loss of the 5' probe; this must have been ...
Without treatment, it frequently progresses to liver fibrosis and eventual cirrhosis requiring liver transplantation or resulting in death. ... in situ or other ...
... in situ treated surgically with curative intent, or other cancers with a similar outcome. Exclusion Criteria Related to Medications: Prior treatment with ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.